Medicare Enrolled
Dr. Frank Melograna, M.D.
Urology Physician · Ormond Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Melograna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melograna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Melograna
Dr. Frank Melograna is an urology physician in Ormond Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Melograna performed 22,282 Medicare services across 2,868 unique beneficiaries.
Between the years covered by Open Payments, Dr. Melograna received a total of $7,298 from 41 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Melograna is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in FL
$7,298 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 140736 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗22,282
Medicare services
Top 5% in FL for urology physician
2,868
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,114 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
16,830 | $0 | $0 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
1,074 | $5 | $25 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
650 | $34 | $86 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
591 | $90 | $325 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
578 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
507 | $65 | $215 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
498 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
322 | $7 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
218 | $120 | $600 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
148 | $34 | $81 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
128 | $11 | $75 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
122 | $68 | $83 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
113 | $10 | $275 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
93 | $47 | $405 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
51 | $144 | $850 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
50 | $34 | $84 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
48 | $34 | $85 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
43 | $35 | $83 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
40 | $22 | $130 |
| Injection, garamycin, gentamicin, up to 80 mg | 28 | $2 | $25 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
27 | $36 | $375 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
21 | $147 | $555 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
19 | $425 | $3,040 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
18 | $292 | $800 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
16 | $27 | $600 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
13 | $283 | $1,000 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
12 | $185 | $470 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
12 | $253 | $1,470 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $81 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,298
Total received (2018-2024)
Avg $1,043/year across 7 years
Top 29% in FL for urology physician
41
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,106 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$192 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$295
2023
$768
2022
$1,833
2021
$1,040
2020
$634
2019
$2,061
2018
$667
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$2,293
NeoTract Inc.
$1,352
Astellas Pharma US Inc
$473
PFIZER INC.
$439
Teleflex LLC
$309
Sumitomo Pharma America, Inc.
$222
Axonics Modulation Technologies, Inc.
$207
Antares Pharma, Inc.
$189
Myovant Sciences Inc.
$168
Boston Scientific Corporation
$162
Endo Pharmaceuticals Inc.
$137
ABBVIE INC.
$137
Janssen Biotech, Inc.
$132
Zyla Life Sciences
$123
Dendreon Pharmaceuticals LLC
$112
Medtronic USA, Inc.
$99
AbbVie, Inc.
$93
Medtronic, Inc.
$91
BOSTON SCIENTIFIC CORPORATION
$55
Coloplast Corp
$47
Ferring Pharmaceuticals Inc.
$46
Avadel Specialty Pharmaceuticals, LLC
$42
Allergan Inc.
$37
Myriad Genetic Laboratories, Inc.
$33
Tolmar, Inc.
$27
TOLMAR Pharmaceuticals, Inc.
$27
Amgen Inc.
$25
Supernus Pharmaceuticals, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Wilmington Medical Supply, Inc.
$18
AbbVie Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$17
Clarus Therapeutics Inc.
$17
Blue Earth Diagnostics Limited
$17
Acerus Pharmaceuticals Corporation
$15
Olympus America Inc.
$15
UroGen Pharma, Inc.
$14
Cook Medical LLC
$14
Janssen Pharmaceuticals, Inc
$12
Zyla Life Sciences, Inc.
$11
Aytu BioScience, Inc
$11
Top 3 companies account for 56.4% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · CONTINENCE CARE · Cook · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL ONCOLOGY · GREENLIGHT · INTERSTIM · JATENZO · JELMYTO · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PROLARIS · PROVENGE · Rezum Generator · SPACEOAR · SPEEDICATH · SPRIX · SpaceOAR VUE System - 10mL · TESTOPEL · TLANDO · TOVIAZ · UROLIFT · UroLift · UroLift System · XGEVA · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $33 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
30
Per 100K population
5.3
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Melograna is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Melograna experienced with testosterone injection?
Based on Medicare claims data, Dr. Melograna performed 16,830 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melograna receive payments from pharmaceutical companies?
Yes. Dr. Melograna received a total of $7,298 from 41 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melograna's costs compare to other urology physicians in Ormond Beach?
Dr. Melograna's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melograna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Ormond Beach
Browse urology physicians in Ormond Beach ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology